Tag: pharmaceuticals
-
Start-Up Developing Immunometabolism Therapies, Gains $30M Funding
A start-up enterprise founded by medical researchers in the U.S. and Europe is developing treatments for cancer and autoimmune disorders that change chemical reactions in immune system cells.
-
Trials to Test Stem Cell Treatments for Eye Injuries
A series of clinical trials are planned to test the use of adult stem cells to treat injuries to the eyes that lead to vision loss.
-
Biotech in $3.7B Licensing Deal for Hepatitis-B
A biotechnology company developing therapies that silence the actions of disease-causing genes is licensing its treatment program for hepatitis-B to Janssen Pharmaceuticals.
-
Human Antibodies Devised for Snakebite Treatment
An academic-industry team in Europe and Central America assembled a group of human antibodies that protects lab mice against venomous toxins from a dangerous African snake.
-
Protein Delivered with Gold Nanoparticles Helps Fix Muscle Injuries
A bioengineering lab at Harvard University devised a technique using gold nanoscale particles to deliver a protein to reduce inflammation from muscle injuries in lab mice.
-
Novartis, NGO Partner on Generic Antibiotics
Drug maker Novartis and a not-for-profit organization delivering antibiotics for low- and middle-income countries are collaborating on production of generic antibiotics for children.
-
Antibody Combination Shown to Suppress HIV
Results from a small-scale clinical trial show a combination of antibodies can suppress the HIV virus for many weeks after stopping antiretroviral therapy.
-
$29.5M Funding Raised for Sinus Drug Delivery Company
A company developing a drug delivery technology to treat chronic sinus conditions is raising $29.5 million in its second venture financing round.
-
Umbilical Cord Grafts Shown to Heal Foot Ulcers
Results from a clinical trial show skin grafts made from dehydrated human umbilical cord tissue heal more diabetic foot ulcers than alginate dressings, a common treatment for the condition.
-
Synthetic Antibody Neutralizing Gluten in Development
An academic-business team is developing a synthetic antibody to prevent gluten found in some grains from affecting the intestines of people with celiac disease, an intolerance of gluten.